Vericel Company Presentation - JPMorgan Healthcare Conference January 14 2026 FINAL No Speaker Notes.pdf

1、Advanced Therapies for the Sports Medicine&Severe Burn Care Markets 44THANNUAL J.P.MORGAN HEALTHCARE CONFERENCEJANUARY 14,2026Safe Harbor2Vericel cautions you that all statements other than statements of historical fact included in this presentation that address activities,events or developments tha

2、t we expect,believe or anticipate will or may occur in the future are forward-looking statements.Although we believe that we have a reasonable basis for the forward-looking statements contained herein,they are based on current expectations about future events affecting us and are subject to risks,as

3、sumptions,uncertainties and factors relating to our operations and business environment,all of which are difficult to predict and many of which are beyond our control.Our actual results may differ materially from those expressed or implied by the forward-looking statements in this presentation.These

4、 statements are often,but are not always,made through the use of words or phrases such as“anticipates,”“intends,”“estimates,”“plans,”“expects,”“continues,”“believe,”“guidance,”“outlook,”“target,”“future,”“potential,”“goals”and similar words or phrases,or future or conditional verbs such as“will,”“wo

5、uld,”“should,”“could,”“may,”or similar expressions.Among the factors that could cause actual results to differ materially from those set forth in the forward-looking statements include,but are not limited to,the inherent uncertainties associated with our expectations concerning revenue results for t

6、he fourth quarter and full-year ended 2025,and estimates of our net income,gross margin,adjusted EBITDA margin and cash and investments as of December 31,2025.Vericels revenue expectations for the fourth quarter and full-year ended 2025,as well as its estimates concerning net income,gross margin,adj